COMP <GO>
VIR vs BFLY // RSI-14 & 200D SMA MOMENTUM
Vir Biotechnology Inc. (NASDAQ) VS. Butterfly Network Inc. (Class A) (NYSE) • 15-METRIC TALLY: VIR 3
— BFLY 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: VIR
LAST: $11.75 (-1.51%) • MKT CAP: $2.01B
rsi-technicals
58.3
LAST: $7.51 (-3.84%) • MKT CAP: $2.00B
rsi-technicals
48.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VIR VS. BFLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VIR | BFLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 46.90% | +49.10 | VIR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -19.74% | -0.80% | -18.94 | BFLY | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -7.60% | 19.00% | -26.60 | BFLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.40 | 7.89 | -5.49 | BFLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 58.3 | 48.7 | +9.60 | VIR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.01B | $2.00B | $9.2M | VIR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VIR REV | BFLY REV | VIR GROSS % | BFLY GROSS % | VIR FCF | BFLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $68.6M | $97.6M | 98.0% | 46.9% | -$396.6M | -$16.0M |
| FY 2024 | $74.2M | $82.1M | 98.0% | 59.5% | -$453.7M | -$44.4M |
| FY 2023 | $86.2M | $65.9M | — | — | -$778.8M | -$98.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VIR // BETA —
BFLY // BETA —